UNSPSC 51393801: Dextrose/dopamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AU100. This VA Drug Class (AU100) classifies this compound as belonging to the group SYMPATHOMIMETICS (ADRENERGICS).

UNSPSC 51393801 Dextrose/dopamine is a Commodity code, but the recent state and local opportunities posted under it involve naloxone procurement and direct-to-manufacturer pharmacy programs rather than dextrose or dopamine pharmaceuticals. Seminole County, Florida issued an IFB on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, while the Texas Health and Human Services Commission released an RFI on April 3, 2026, to explore vendor capabilities for a direct-to-manufacturer prescription program. The mismatch between the code's nominal scope and the actual work being solicited suggests this code sees limited relevant recent activity aligned with its stated commodity classification.

Seminole County's naloxone solicitation (IFB 60459723LAS, due July 26, 2023) represents the only concrete state and local opportunity under this code with defined quantities and delivery terms. The Texas RFI is exploratory in nature with no award values, budget ranges, or binding timelines specified. The issuing bodies are a county government and a state HHS agency. Geographic activity appears concentrated in Florida and Texas based on the two posted opportunities, though the sparse recent record and the code-scope misalignment limit confidence in characterizing broader activity patterns. Neither solicitation specifies set-aside designations for disadvantaged enterprises. The code shows minimal recent relevant procurement activity; business development professionals should verify whether opportunities in this category are systematically miscoded or if activity has shifted to other UNSPSC classifications for pharmaceutical procurement.